Company / Operating Income per Share
ANI Pharmaceuticals, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$5.26
FY2025
5-year range
-$3.16 / $5.26
FY2021-FY2025
Trend
+14553.6%
vs FY2024
Sector context
#16 of 201
Health Care
What the data says
Operating Income per Share changed +14554% YoY in FY2025, a notable deviation from the 9-year average annual change of +1598%.
Based on SEC 10-K filings.
5.26 in FY2025. Top quartile in the Health Care sector.
Improved from $2.58 to $5.26 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 201This company $5.26 Sector average -$28.56
▼
+118.4% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 14553.6% year-over-year.
- Ranks #16 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.26 | +14553.6% |
| FY2024 | $0.04 | -98.6% |
| FY2023 | $2.58 | +219.0% |
| FY2022 | -$2.17 | +31.3% |
| FY2021 | -$3.16 | -136.0% |
| FY2020 | -$1.34 | -194.5% |
| FY2019 | $1.42 | -52.9% |
| FY2018 | $3.00 | +22.5% |
| FY2017 | $2.45 | +41.3% |
| FY2016 | $1.73 | -99.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026